Name (Synonyms) | Correlation | |
---|---|---|
drug2545 | Traditional antirheumatic drugs Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D001171 | Arthritis, Juvenile NIH | 0.71 |
D001168 | Arthritis NIH | 0.41 |
D001172 | Arthritis, Rheumatoid NIH | 0.27 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0001369 | Arthritis HPO | 0.41 |
HP:0001370 | Rheumatoid arthritis HPO | 0.27 |
There are 2 clinical trials
In the context of the COVID19 pandemic and containment, chest CT is currently frequently performed on admission, looking for suggestive signs and basic abnormalities of COVID19 compatible viral pneumonitis pending confirmation of identification of viral RNA by reverse-transcription polymerase chain reaction(PCR), with a reported sensitivity of 56-88% in the first few days, slightly higher than PCR (60%) (1). Nevertheless, currently established radiological abnormalities are not specific for COVID19 and the specificity of the chest CT is ~25% when PCR is used as a reference (1). Deconfinement and its consequences will complicate the triage of COVID patients and the role of the scanner, with the expected impact of a decrease in the prevalence of infection in the emergency department and an increase in the number of "all-round" patients, including patients with non-COVID viral infiltrates or pneumopathies. In addition, there are currently no imaging criteria to complement the clinical and biological data that can predict the progression of lung disease from the initial data.
Description: The diagnostoc of COVID disease is composite of: CT features wich will include presence/location/laterality of morphological CT abonormal densities (ground glass opacities, consolidations, reticulations), pulmonary vessels size, distribution and abnormalities, local / global CT-ventilation index (CT-VI) severity, radiomic features (shape features, 1st-order and 2nd order statistics) Analysis of CT-Scan results.
Measure: diagnostic of COVID disease composite Time: On admission to the hospitalThe most common thorax Computed tomography (CT) findings are multifocal ground-glass opacities and peripheral consolidation in patients with COVID-19. Septal thickening, bronchiectasis, pleural thickening, and subpleural involvement may also be observed. Although these findings are not specific to COVID-19, the severity of pulmonary involvement is expected to be correlated with thorax CT findings.
Description: Whether Thorax CT findings predict invasive mechanical ventilation requirement of covid-19 patients
Measure: Invasive respiratory support in patients with COVID-19 Time: 120 daysDescription: Whether Thorax CT findings predict mortality of covid-19 patients
Measure: Mortality in patients with COVID-19 Time: 120 days